Mesothelioma Cure Proves Illusive

Unfortunately for mesothelioma patients, researchers announced today that the results are in - and very disappointing - for the largest study ever conducted for advanced malignant pleural mesothelioma. In particular, Zolinza (vorinostat), the drug that many in the medical and mesothelioma communities had hoped would revolutionize the treatment of the leading asbestos-related disease, has proven totally ineffective against mesothelioma.

This news is particularly disappointing considering that the study was led by leading researchers, including doctors from New York City's prestigious Memorial Sloan-Kettering Cancer Center. The study was comprehensive, including 660 patients and according to a researcher at University Hospital in Zurich, Switzerland, was the biggest study of its kind to date. The worst news is that not only are upwards of 3,000 Americans diagnosed with mesothelioma every year, but that number is expected to increase in the years ahead and peak between 2015 and 2020. Victims need a medical solution!

Fears | Nachawati closely follows the latest medical and legal developments for asbestos-related diseases such as mesothelioma, asbestosis, and lung cancer. With years of experience fighting for victims' rights, we specialize in defending the legal interests of mesothelioma patients. If you or a loved one has been injured as a result of asbestos exposure, you should contact us immediately. For your free consultation, call 1.888.550.4913 or visit http://www.asbestosmesotheliomalawyer.us/Contact-Us.aspx.